more_reports

Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

TICKERS: DRO; DRSHF

DroneShield Uncovers Record Revenue Gains in Australia
Research Report

View Important Disclosures for this Article
Share on Stocktwits

Source:

DroneShield Ltd. (DRO:ASX; DRSHF:OTC) achieves a record-breaking first half of 2025, with revenue soaring 210% year-over-year to AU$72.3 million and a net profit after tax of AU$2.1 million. See why one analyst thinks the company's outlook remains strong.

DroneShield Ltd. (DRO:ASX; DRSHF:OTC) achieved a record-breaking first half of 2025, with revenue soaring 210% year-over-year to AU$72.3 million and a net profit after tax of AU$2.1 million, marking a significant turnaround from an AU$4.8 million loss in the first half of 2024, wrote Shaw and Partners Analyst Abraham Akra in an updated research note on August 28.

EBITDA increased to AU$5.2 million, compared to a negative AU$4.9 million in the previous corresponding period. Cash receipts rose 185% year-over-year to AU$60.7 million. With revenue visibility for fiscal year 2025 at AU$176.3 million, compared to AU$57.5 million in FY24.

"Most deliveries expected to completed in 2H25, the 2H outlook remains strong," Akra wrote.

Leidos Secures LAND 156 Systems Integration Role

Leidos Australia has been chosen by the Australia Department of Defense as the Systems Integration Partner for the LAND 156 project under an AU$45.9 million contract. This initiative aims to establish a modular, sovereign counter-small unmanned aerial systems (C-sUAS) capability for addressing Group 1–2 threats. The initial capability, featuring Acacia’s Cortex C2, EOS’s Slinger effector, and Department 13 sensors, will be showcased at Southern Arrow 25 in December 2025.

Although DroneShield was not selected for this role, there is optimism about its involvement in future phases and complementary layers, given the Australian government’s AU$1.3 billion allocation for counter-drone acquisitions within the Integrated Investment Program, Akra noted.

Strong Cash Position and No Debt

DroneShield concluded June with AU$204 million in cash and term deposits. Although fixed operating cash costs have risen to approximately AU$8.5 million per month from AU$6.5 million in the first quarter, this is supported by increasing revenue and strong gross profit margins of around 71%, according to Akra. With no debt and approximately AU$270 million in saleable inventory (book value: AU$81 million), the company is well-positioned to self-fund its growth, including manufacturing expansion.

DroneShield is implementing a strategy to increase manufacturing capacity from AU$0.5 billion to AU$2.4 billion annually by FY26 through contract manufacturing in the US and EU, and the commissioning of a new 3,000 square meter production line in Sydney, the report said.

Headcount reached 373 by August, up from 250 at the end of FY24, including 285 engineers supporting quarterly AI software upgrades. These systems support the delivery of next-generation hardware, increased SaaS attach rates, and repeat revenue throughout the product lifecycle.

"These systems underpin the delivery of next-gen hardware, increased SaaS attach rates, and repeat revenue across the product lifecycle," Akra wrote.

Expanding Market via Civilian SaaS and Regional Growth

While defense remains a core focus, DroneShield is expanding into civilian infrastructure with SentryCiv, a subscription-only, detect-only product targeting airports, utilities, and stadiums, the analyst said. SaaS revenue, although only 5% of group revenue in the first half of 2025, grew 177% year-over-year, driven by an expanding AI feature set. Regionally, revenue from Europe (16%) and Asia-Pacific (27%) is increasing, although the US (20%) remains a key market. This highlights the growing global demand for counter-drone solutions.

DroneShield’s qualified pipeline has expanded to AU$2.34 billion across 310 active projects, according to Akra's report. Notably, 13 opportunities exceed AU$30 million, and 52 are over AU$5 million. Europe now leads in opportunity volume, benefiting from the €800 billion ReArm Europe defense expenditure.

Key upcoming catalysts for DRO include converting the existing pipeline into further FY25/26 orders and expanding SaaS revenues linked to new hardware launches in 2026.

Minimal Changes to Earnings Forecasts

Revenue forecasts for FY25–27 remain largely unchanged, with EBITDA stable and net profit after tax adjusted by +2.6%, +7.9%, and -5.6% for FY25–27, primarily due to net interest on revised yield assumptions, Akra said.

"We rate DRO at Buy with a US$3.60 PT (unchanged)," Akra wrote. "Our valuation is a blend of DCF and SOTP. We see DRO reaching an inflection point in sales and profitability with the NATO agreement supplementing the U.S. Dept of Defense recommendation and solidifying DRO as a market leader in jamming C-UAS."


Want to be the first to know about interesting Technology and Special Situations investment ideas? Sign up to receive the FREE Streetwise Reports' newsletter. Subscribe

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of DroneShield Ltd.
  2. Steve Sobek wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
  3. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company. 

For additional disclosures, please click here.

Disclosures for Shaw and Parnters, DroneShield Ltd., August 28, 2025:

Shaw and Partners Limited ABN 24 003 221 583 (“Shaw”) is a Participant of ASX Limited, Cboe Australia Pty Limited and holder of Australian Financial Services Licence number 236048.

ANALYST CERTIFICATION: The Research Analyst who prepared this report hereby certifies that the views expressed in this document accurately reflect the analyst's personal views about the Company and its financial products. Neither Shaw nor its Research Analysts received any direct financial or non-financial benefits from the company for the production of this document. However, Shaw Research Analysts may receive assistance from the company in preparing their research which can include attending site visits and/or meetings hosted by the company. In some instances the costs of such site visits or meetings may be met in part or in whole by the company if Shaw considers it is reasonable given the specific circumstances relating to the site visit or meeting. As at the date of this report, the Research Analyst does not hold, either directly or through a controlled entity, securities in the Company that is the subject of this report, or where they do hold securities those interests are not material. Shaw restricts Research Analysts from trading in securities outside of the ASX/S&P100 for which they write research. Other Shaw employees may hold interests in the company, but none of those interests are material.

DISCLAIMER: This report is published by Shaw to its clients by way of general, as opposed to personal, advice. This means it has been prepared for multiple distribution without consideration of your investment objectives, financial situation and needs (“Personal Circumstances”). Accordingly, the advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not the advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of your Shaw client adviser. This report is provided to you on the condition that it not be copied, either in whole or in part, distributed to or disclosed to any other person. If you are not the intended recipient, you should destroy the report and advise Shaw that you have done so. This report is published by Shaw in good faith based on the facts known to it at the time of its preparation and does not purport to contain all relevant information with respect to the financial products to which it relates. The research report is current as at the date of publication until it is replaced, updated or withdrawn. Although the report is based on information obtained from sources believed to be reliable, Shaw does not make any representation or warranty that it is accurate, complete or up to date and Shaw accepts no obligation to correct or update the information or opinions in it. If you rely on this report, you do so at your own risk. Any projections are indicative estimates only and may not be realised in the future. Such projections are contingent on matters outside the control of Shaw (including but not limited to market volatility, economic conditions and company-specific fundamentals) and therefore may not be realised in the future. Past performance is not a reliable indicator of future performance. Except to the extent that liability under any law cannot be excluded, Shaw disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence. Depending on the timing and size of your investment, your portfolio composition may differ to the model. Performance figures are derived from the inception date of the model and its investment transactions from that date, therefore the performance for your portfolio may be different. If you have any questions in connection with differences between your portfolio and the model, you should speak with your adviser.

For U.S. persons only: This research report is a product of Shaw and Partners Limited under Marco Polo Securities 15a-6 chaperone service, which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account.

Research reports are intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a-6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Shaw and Partners Limited has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be affected through Marco Polo or another U.S. registered broker dealer.

DISCLOSURE: Shaw will charge commission in relation to client transactions in financial products and Shaw client advisers will receive a share of that commission. Shaw, its authorised representatives, its associates and their respective officers and employees may have earned previously or may in the future earn fees and commission from dealing in the Company's financial products. Shaw acted as Sole/Joint Lead Manager and Underwriter in the last 12m of the placement of DRO securities for which it received fees or will receive fees for acting in this capacity. Accordingly, Shaw may have a conflict of interest which investors should consider before making an investment decision.





Want to read more about Technology and Special Situations investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe